Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia–reperfusion injury

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Anesthesia

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00540-013-1716-3PMID 24113863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-κB and upregulation of autophagy

  2013cited by this paper
• Necrostatin-1 Suppresses Autophagy and Apoptosis in Mice Traumatic Brain Injury Model

  2012cited by this paper
• A novel role for RIP1 kinase in mediating TNFα production

  2012cited by this paper
• Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia.

  2012cited by this paper
• Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis.

  2011cited by this paper
• Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia–reperfusion

  2010cited by this paper
• MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1

  2010cited by this paper
• RIP kinases at the crossroads of cell death and survival.

  2009cited by this paper
• Cardioprotective signaling to mitochondria.

  2009cited by this paper
• Identification of RIP1 kinase as a specific cellular target of necrostatins.

  2008influential reference
• Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.

  2008cited by this paper
• Necrostatin: A Potentially Novel Cardioprotective Agent?

  2007cited by this paper
• The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore

  2007cited by this paper
• Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury

  2005influential reference
• Apoptosis of Endothelial Cells Precedes Myocyte Cell Apoptosis in Ischemia/Reperfusion Injury

  2001cited by this paper
• Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury

  2000cited by this paper
• What is the Required Reperfusion Period for Assessment of Myocardial Infarct Size Using Triphenyltetrazolium Chloride Staining in the Rat?

  2000cited by this paper
• Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule

  2000cited by this paper
• Caspase-independent programmed cell death with necrotic morphology

  1999cited by this paper
• Apoptosis in Myocardial Ischemia‐Reperfusion

  1999cited by this paper
• Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor.

  1998cited by this paper
• Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.

  1996cited by this paper
• Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

  1981cited by this paper

• Molecular and Cellular Mechanisms of Myocardial Ischemia and Reperfusion Injury: A Narrative Review

  2026cites this paper
• Temporal regulation of genetic programs governing multiple cell death during myocardial ischemia-reperfusion injury

  2025cites this paper
• A bibliometric analysis of the literature published on autophagy, ferroptosis, necroptosis, and pyroptosis in cardiovascular disease from 2009 to 2023

  2025cites this paper
• Z-DNA-binding protein 1 exacerbates myocardial ischemia‒reperfusion injury by inducing noncanonical cardiomyocyte PANoptosis

  2025cites this paper
• PANoptosis: a potential target of atherosclerotic cardiovascular disease

  2025cites this paper
• Different types of cell death and their interactions in myocardial ischemia–reperfusion injury

  2025cites this paper
• Roles of different methylation modifications in cardiovascular disease

  2025cites this paper
• Dalbergia odorifera Trans-Nerolidol Protects Against Myocardial Ischemia via Downregulating Cytochrome- and Caspases-Signaling Pathways in Isoproterenol-Induced Rats

  2025cites this paper
• Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: a review of evidence from animal and clinical studies

  2025cites this paper
• Natural product library screening identifies Darutigenol for the treatment of myocardial infarction and ischemia/reperfusion injury

  2025cites this paper
• Circulating microRNA-1 as a diagnostic biomarker for acute myocardial infarction: a meta-analysis

  2025cites this paper
• PANoptosis: Novel insight into regulated cell death and its potential role in cardiovascular diseases (Review)

  2024cites this paper
• Halcinonide activates smoothened to ameliorate ischemic stroke injury.

  2024cites this paper
• Mechanisms and Therapeutic Potential of Multiple Forms of Cell Death in Myocardial Ischemia–Reperfusion Injury

  2024cites this paper
• Regulated Cell death in Acute Myocardial Infarction: Molecular Mechanisms and Therapeutic Implications.

  2024cites this paper
• The Chinese Herbal Medicine Li Qi Huo Xue Di Wan Ameliorates Ischemia or Hypoxia‐Induced Cardiac Injury and Remodeling in the Heart Through a Mechanism Involving Reduction of Necroptosis

  2024cites this paper
• Tilianin suppresses NLRP3 inflammasome activation in myocardial ischemia/reperfusion injury via inhibition of TLR4/NF-κB and NEK7/NLRP3

  2024cites this paper
• Targeting SARS-CoV-2-Induced Cardiovascular Injury: Exploring the Potential of Ponatinib in Mitigating Cardiovascular Necroptosis in COVID-19.

  2024cites this paper
• PANoptosis: a novel target for cardiovascular diseases.

  2024cites this paper
• Angiotensin II Is Involved in MLKL Activation During the Development of Heart Failure Following Myocardial Infarction in Rats.

  2024cites this paper
• Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy

  2023cites this paper
• Regulated cell death in myocardial ischemia-reperfusion injury.

  2023cites this paper
• An investigation of the distributions of ferroptosis and necroptosis mediators in the maternal–fetal interface at different days of rat pregnancy

  2023cites this paper
• RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications

  2023cites this paper
• Ferroptosis inhibitor improves cardiac function more effectively than inhibitors of apoptosis and necroptosis through cardiac mitochondrial protection in rats with iron-overloaded cardiomyopathy.

  2023cites this paper
• Dalbergia odorifera Essential oil protects against myocardial ischemia through upregulating nrf2 and inhibiting caspase signaling pathways in isoproterenol-induced rats

  2023cites this paper
• Nekroptozis: Serebral ve Miyokardiyal İskemi/Reperfüzyon Hasarı için Terapötik bir Hedef midir?

  2023cites this paper
• Pharmaceutical Therapies for Necroptosis in Myocardial Ischemia–Reperfusion Injury

  2023cites this paper
• Treatment with apoptosis inhibitor restores cognitive impairment in rats with myocardial infarction.

  2023cites this paper
• Novel, non-conventional pathways of necroptosis in the heart and other organs: Molecular mechanisms, regulation and inter-organelle interplay.

  2023cites this paper
• Panaxynol ameliorates cardiac ischemia/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1/TLR4/NF-κB axis.

  2023cites this paper
• Necrostatin-1 attenuates delayed paraplegia after transient spinal cord ischemia in rabbits by inhibiting the upregulation of receptor-interacting protein kinase 1 and 3.

  2023cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications

  2023cites this paper
• Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury

  2022cites this paper
• Necroptosis: A Pathogenic Negotiator in Human Diseases

  2022cites this paper
• Role of AMPK in Myocardial Ischemia-Reperfusion Injury-Induced Cell Death in the Presence and Absence of Diabetes

  2022cites this paper
• The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury

  2022influential citation
• Current knowledge of pyroptosis in heart diseases.

  2022cites this paper
• Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury

  2022cites this paper
• Necroptosis in heart disease: Molecular mechanisms and therapeutic implications.

  2022cites this paper
• Pyroptosis: Role and Mechanisms in Cardiovascular Disease

  2022cites this paper
• Maslinic Acid Inhibits Myocardial Ischemia–Reperfusion Injury-Induced Apoptosis and Necroptosis via Promoting Autophagic Flux

  2022cites this paper
• Reperfusion Cardiac Injury: Receptors and the Signaling Mechanisms

  2022cites this paper
• Iron overload cardiomyopathy: Using the latest evidence to inform future applications

  2022cites this paper
• Mitochondria and Pharmacologic Cardiac Conditioning—At the Heart of Ischemic Injury

  2021cites this paper
• Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases

  2021cites this paper
• Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.

  2021cites this paper
• Cardiomyocytes Cellular Phenotypes After Myocardial Infarction

  2021cites this paper
• Inhibition of Cardiac RIP3 Mitigates Early Reperfusion Injury and Calcium-Induced Mitochondrial Swelling without Altering Necroptotic Signalling

  2021cites this paper
• RhoA Signaling in Immune Cell Response and Cardiac Disease

  2021cites this paper
• Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury

  2021cites this paper
• Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury.

  2021cites this paper
• Targeting necroptosis as therapeutic potential in chronic myocardial infarction

  2021cites this paper
• Protective Effect of Mitochondrially Targeted Peptide Against Oxidant Injury of Cone Photoreceptors Through Preventing Necroptosis Pathway.

  2021cites this paper
• Cardiac Shock Wave Therapy Alleviates Hypoxia/Reoxygenation-Induced Myocardial Necroptosis by Modulating Autophagy

  2021cites this paper
• Necroptosis and RhoA/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia/reperfusion injury in a rat model

  2021cites this paper
• Agarwood Alcohol Extract Ameliorates Isoproterenol-Induced Myocardial Ischemia by Inhibiting Oxidation and Apoptosis

  2020cites this paper
• Reperfusion injury as a target for diminishing infarct size.

  2020cites this paper
• Neuroprotective Effects of Necrostatin-1 Against Oxidative Stress–Induced Cell Damage: an Involvement of Cathepsin D Inhibition

  2020cites this paper
• Long non-coding RNA GAS5 regulates myocardial ischemia-reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR-532-5p

  2020cites this paper
• Arctiin protects rat heart against ischemia/reperfusion injury via a mechanism involving reduction of necroptosis.

  2020cites this paper
• Mitochondrial and mitochondrial‐independent pathways of myocardial cell death during ischaemia and reperfusion injury

  2020cites this paper
• Necroptosis of osteoblasts was induced by breast cancer cells in vitro

  2020cites this paper
• Regulation of cell death in the cardiovascular system.

  2020cites this paper
• Necroptosis inhibition prevents long-term cardiac damage during pneumococcal pneumonia and invasive disease.

  2020cites this paper
• Myocardial ischaemia–reperfusion injury and cardioprotection in perspective

  2020cites this paper
• The role of RIPK3‐regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia‐reperfusion injury

  2020cites this paper
• Pre- and post-conditioning of the heart: an overview of cardioprotective signaling pathways.

  2020cites this paper
• Sevoflurane postconditioning reduces myocardial ischemia reperfusion injury-induced necroptosis by up-regulation of OGT-mediated O-GlcNAcylated RIPK3

  2020cites this paper
• Mouse models of atherosclerosis and their suitability for the study of myocardial infarction

  2020cites this paper
• Hypothermia Inhibits Cerebral Necroptosis and NOD-Like Receptor Pyrin Domain Containing 3 Pathway in a Swine Model of Cardiac Arrest.

  2019cites this paper
• Different signalling in infarcted and non‐infarcted areas of rat failing hearts: A role of necroptosis and inflammation

  2019cites this paper
• Egr-1 functions as a master switch regulator of remote ischemic preconditioning-induced cardioprotection

  2019cites this paper
• Estrategias multi-diana para reducir la lesión miocárdica de isquemia/reperfusión. Revisión JACC Tema de la semana

  2019cites this paper
• Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

  2019cites this paper
• Oxytocin protects against 3-NP induced learning and memory impairment in rats: sex differences in behavioral and molecular responses to the context of prenatal stress.

  2019cites this paper
• Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis.

  2019cites this paper
• Novel findings and therapeutic targets on cardioprotection of ischemia/reperfusion injury in STEMI.

  2019cites this paper
• Assessment of Tiron as a cardioprotective agent

  2019cites this paper
• Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.

  2019cites this paper
• Simultaneous Suppression of Multiple Programmed Cell Death Pathways by miRNA-105 in Cardiac Ischemic Injury

  2019cites this paper
• Silencing of A20 Aggravates Neuronal Death and Inflammation After Traumatic Brain Injury: A Potential Trigger of Necroptosis

  2019cites this paper
• Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury.

  2019cites this paper
• Cox-2 Negatively Affects the Protective Role of Propofol against Hypoxia/Reoxygenation Induced Cardiomyocytes Apoptosis through Suppressing Akt Signaling

  2019cites this paper
• Pure Polyphenols Applications for Cardiac Health and Disease.

  2018cites this paper
• Necroptosis

  2018cites this paper
• Protective effects of paeoniflorin on myocardial injury induced by sepsis via calpain / caspases-3

  2018cites this paper
• Necroptosis occurs in osteoblasts during tumor necrosis factor-α stimulation and caspase-8 inhibition

  2018cites this paper
• Targeting necroptotic cell death pathway by high-intensity interval training (HIIT) decreases development of post-ischemic adverse remodelling after myocardial ischemia / reperfusion injury

  2018cites this paper
• Necroptosis: a regulated inflammatory mode of cell death

  2018cites this paper
• The Role of Necroptosis in Cardiovascular Disease

  2018cites this paper
• Cardioprotection of ischaemic preconditioning is associated with inhibition of translocation of MLKL within the plasma membrane

  2018influential citation
• Using drugs to target necroptosis: dual roles in disease therapy.

  2018cites this paper
• Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond

  2018cites this paper
• Necroptosis in cardiovascular disease - a new therapeutic target.

  2018cites this paper
• Araloside C Prevents Hypoxia/Reoxygenation-Induced Endoplasmic Reticulum Stress via Increasing Heat Shock Protein 90 in H9c2 Cardiomyocytes

  2018cites this paper
• Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets

  2018cites this paper
• AMP-activated protein kinase protects against necroptosis via regulation of Keap1-PGAM5 complex.

  2018cites this paper
• New and revisited approaches to preserving the reperfused myocardium

  2017cites this paper